Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Drug Interaction Study of Henagliflozin and Simvastatin in Healthy Volunteers

Trial Profile

Drug Interaction Study of Henagliflozin and Simvastatin in Healthy Volunteers

Status: Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Oct 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Henagliflozin (Primary) ; Simvastatin
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Jiangsu Hengrui Medicine Co.
  • Most Recent Events

    • 07 Nov 2017 Planned End Date changed from 27 Nov 2017 to 8 Dec 2017.
    • 07 Nov 2017 Planned primary completion date changed from 20 Nov 2017 to 4 Dec 2017.
    • 07 Nov 2017 Planned initiation date changed from 1 Oct 2017 to 24 Nov 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top